Gimeracil 2025: Technical Guide & Application Insights

Contents

1. Product Overview & Specifications

Parameter Gimeracil 2025 Competitor A Competitor B
Purity ≥99.8% 99.5% 99.2%
Storage Temp -20°C±2°C Room Temp -15°C to -25°C
Solubility Water-soluble Organic solvents Limited solubility
Certifications GMP, ISO9001 ISO9001 Non-certified

2. Key Applications & Use Cases

Pharmaceutical Manufacturing: Potentiates 5-FU chemotherapy efficacy while reducing myelosuppression risks in colorectal/gastric cancer treatment regimens.

Research Applications: Used in pharmacokinetic studies for dose optimization and combination therapy development.

3. Industry-Specific Usage Guidelines

Dosage Protocol: 10-15mg/m² combined with 5-FU in FOLFOX regimens, adjusted for renal function (CrCl <50ml/min requires 20% dose reduction).

Solution Preparation: Reconstitute with sterile water for injection at 5mg/ml concentration, stable for 48hrs at 2-8°C.

4. Client Success Stories

Case 1: European Pharma Co. achieved 22% reduction in neutropenia rates using Gimeracil 2025 in mCRC trials (N=450 patients).

Case 2: Asian Research Institute improved tumor response rates from 38% to 52% in gastric cancer models through optimized dosing schedules.

5. Technical Support & Inquiry

Contact our formulation experts for batch-specific COA or clinical trial support:

Email: info@vivalr.com
Phone: (86) 15866781826

0.00
0 条评论
5
0
4
0
3
0
2
0
1
0
成为第一个评论 “Gimeracil”

您的邮箱地址不会被公开。 必填项已用 * 标注

这是必填栏。

这是必填栏。

这是必填栏。

评论

目前还没有评论。

类别 
我的购物车
愿望清单
最近浏览
类别
Wait! before you leave…
Get 30% off for your first order
CODE30OFFCopy to clipboard
Use above code to get 30% off for your first order when checkout
比较产品 (0 产品)